Patent Foramen Ovale (PFO) in Patients of Cryptogenic Stroke AND Transient Ischemic Attack (TIA): A Real World Experience
Muzzafar Mohi-Ud-Din Hakeem
Department of Neurology Batra Hospital and Medical Research Center, India.
Nadeem U Rehman
Department of Neurology Batra Hospital and Medical Research Center, India.
Madhukar H.M
Department of Cardiology, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bengaluru, Karnataka, India.
H.S Natraj Setty *
Department of Cardiology, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bengaluru, Karnataka, India.
*Author to whom correspondence should be addressed.
Abstract
Background: Stroke, a leading cause of brain tissue damage, presents a significant health concern globally. Cryptogenic stroke (CS), with an unclear origin, poses diagnostic challenges, with the patent foramen ovale (PFO) implicated in some cases. This study aims to investigate PFO prevalence in North India among patients with cryptogenic stroke, addressing current research gaps.
Objective: To assess PFO occurrence in patients with cryptogenic stroke and Transient Ischemic Attack (TIA) using Echocardiography.
Methods & Results: This preliminary study analyzed PFO prevalence in patients with CS and TIA from February 2020 to November 2021, involving 25 participants. Descriptive statistics and the Chi-square test were employed. Key findings include a mean age of 44.80±9.13 years, 64% men, and 36% women. Ischemic stroke accounted for 72% of cases, while TIA represented 28%. PFO prevalence was 44%, with no significant gender-PFO association. No correlations were found between stroke type and PFO presence, nor were comorbidities like hypertension and diabetes observed.
Conclusion: The study highlights a clinically significant distribution of PFO presence but no notable association between stroke type and PFO presence. These findings contribute to understanding PFO's role in cryptogenic stroke and have implications for clinical practice.
Keywords: Cryptogenic stroke, patent foramen ovale (PFO), echocardiography, cardioembolism
How to Cite
Downloads
References
Jeyaraj Durai Pandian et.al Stroke Epidemiology and Stroke Care Services in India. J Stroke. 2013 Sep;15(3):128–134.
López AD. WHO dies of what? A comparative analysis of mortality conditions in developed countries around 1987. World Health Stat Q 1990;43:105-14.
Vahdati SS, Ala A, Aghdas SA, Adib A, Mirza-Aghazadeh-Attari M, Aliar F. Association between the subtypes of stroke and the various risk factors of cerebrovascular accidents: A cross-sectional study. The Eurasian journal of medicine. 2018 Jun;50(2):86.
Tomas Abadal L, Puig T, Balaguer Vintró I. Accidente vascular cerebral: incidencia, mortalidad y factores de riesgo en 28 años de seguimiento. Estudio de Manresa. Rev Esp Cardiol. 2000;53:15-20.
Manning WJ. Role of transesophageal echocardiography in the management of thromboembolic stroke. Am J Cardiol. 1997;80:D19-28.
Mas JL, Lascault G, Loron P, Theard M, Klimczac M, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med. 1988;318:1148-52.
Al sheikh-Ali AA, Thaler DE, Kent DM. Patent foramen ovale in cryptogenic stroke: incidental or pathogenic. Epub. 2009 May 14;40:2349–55.
Mojadidi MK, Elgendy AY, Elgendy IY, et al. Transcatheter patent foramen ovale closure after cryptogenic stroke: an updated meta-analysis of randomized trials. JACC Cardiovasc Interv; 2017.
DOI:10:2228–30. 10.1016/j.jcin.2017.09.002.
The New England Journal of Medicine, May 2016. N Engl J Med. May 26, 2016;374:21.
DM Kent. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Epub. 2013 Jul 17;81(7):619–625.
Marino Brian, Abhishek Jaiswal, Seth Goldbarg, Gary L. Berardini. Impact of transesophageal echocardiography on clinical management of patients over age 50 with cryptogenic stroke and normal transthoracic echocardiogram. J. Hosp. Med. 2016;11(2):95-98 DOI:10.1002/jhm.2484.
Li L, Schulz UG, Kuker W, Rothwell PM. Oxford Vascular Study. Age-specific association of migraine with cryptogenic TIA and stroke: Population-based study. Neurology. 2015;85(17):1444–1451.
Available:https://doi.org/10.1212/WNL.0000000000002059.
Dolores Mesa. Prevalence of Patent Foramen Ovale in Young Patients with Cryptogenic Stroke, Revista Española de Cardiología. 2003;662-668 (Julio 2003).
Homma S, Di Tullio MR, Characteristics of patent foramen ovale associated with cryptogenic stroke. A biplane transesophageal echocardiographic study. Stroke. 1994 Mar;25(3):582-6.
D C Fisher, E A Fisher, J H Budd, S E Rosen, M E Goldman. The incidence of patent foramen ovale in 1,000 consecutive patients. A contrast transesophageal echocardiography study. Chest. 1995; 107(6):1504-9. DOI: 10.1378/chest.107.6.1504.
Di Tullio M, Sacco RL, Gopal A, Mohr JP, Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992;117:461-5.
De Castro, October 2000.Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke. 2000;31:2407–2413.
Wu LA. Patent foramen ovale in cryptogenic stroke: Current understanding and management options. Arch Intern Med 2004 May 10;164(9):950-6.
Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A. Patent foramen ovale and cryptogenic stroke in older patients. N Eng J Med. 2007;357:2262–8. DOI: 10.1056/NEJMoa071422.